Top

Published in:

01-05-2006 | Original Article

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

Authors: Amit Khanna, M.D., M.P.H., Gail R. Walker, Ph.D., Alan S. Livingstone, M.D., Kristopher L. Arheart, Ph.D., Caio Rocha-Lima, M.D., Leonidas G. Koniaris, M.D.

Published in: Journal of Gastrointestinal Surgery | Issue 5/2006

Title: Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question
Authors: Amit Khanna, M.D., M.P.H.
Gail R. Walker, Ph.D.
Alan S. Livingstone, M.D.
Kristopher L. Arheart, Ph.D.
Caio Rocha-Lima, M.D.
Leonidas G. Koniaris, M.D.
Publication date: 01-05-2006
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 5/2006
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1016/j.gassur.2005.11.006

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 5/2006

Stapled hemorrhoidectomy

Comparison of results of surgery in the upper third and more distal stomach

How should complex perianal Crohn's disease be treated in the Remicade era?

2005 SSAT/ASCRS Joint Symposium What's New in the Management of Anal Disease?

Identification of Helicobacter pylori biofilms in human gastric mucosa

An approach to analyze mechanisms of intestinal adaptation following total proctocolectomy